Exarmed Pharma Private Limited

Pharmaceutical company that markets, sources, and trades basic drugs and chemicals.

2019 | Medak, Telangana (India) | Converted to LLP
Last Updated: October 23, 2024

Exarmed Pharma Profile

Key Indicators

  • Authorised Capital ₹ 13.50 Cr
  • Paid Up Capital ₹ 13.50 Cr
  • Company Age 6 Year, 1 Month
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth 109.07%
  • Profit Growth 358.57%
  • Ebitda 358.57%
  • Net Worth 0.27%
  • Total Assets 1.21%

About Exarmed Pharma

Exarmed Pharma Private Limited (EPPL) is Converted To Llp company established on 08 Jan 2019 with its office registered at Medak, Telangana, India and has been running since 6 Year, 1 Month with a paid up capital of 13.50 Cr. According to MCA records, 3 Directors and 1 Signatories are linked to this company as of 23 Oct 2024.

Company Details

  • Location

    Medak, Telangana, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24110TG2019PTC129565

  • Company No.

    129565

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    08 Jan 2019

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Hyderabad

Industry

Pharma

Who are the key members and board of directors at Exarmed Pharma?

Executive Team (1)

NameDesignationAppointment DateStatus
Ganamoor Reddy Country flag representing In Company Secretary01-Nov-2022Current

Board Members (3)

NameDesignationAppointment DateStatus
Vajrala Bhulakshmi Country flag representing In Director 08-Jan-2019Current
Jahnavi Puchakayala Country flag representing In Director 08-Jan-2019Current
Bala Thippabhotla Country flag representing In Director 01-Jul-2019Current

Financial Performance of Exarmed Pharma.

Exarmed Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 109.07% increase. The company also saw a substantial improvement in profitability, with a 358.57% increase in profit. The company's net worth moved up by a moderate rise of 0.27%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
109.07%
Revenue from Operations
109.07%
Total Assets
1.21%
Profit or Loss
358.57%
Net Worth
0.27%
EBITDA
358.57%

What is the Ownership and Shareholding Structure of Exarmed Pharma?

In 2023, Exarmed Pharma had a promoter holding of 65.79% and a public holding of 34.21%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Exarmed Pharma?

Unlock and access historical data on people associated with Exarmed Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Exarmed Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Exarmed Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Exarmed Pharma

Recent activity within the organization

  • Annual General Meeting

    Exarmed Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

    30 Sep 2023

  • Balance Sheet

    Exarmed Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.

    31 Mar 2023

  • Director Appointment

    Ganamoor Madhusudhan Reddy was appointed as a Company Secretary was appointed as a Company Secretary on 01 Nov 2022 & has been associated with this company since 2 years 3 months .

    01 Nov 2022

  • Director Appointment

    Bala Murali Krishna Thippabhotla was appointed as a Director was appointed as a Director on 01 Jul 2019 & has been associated with this company since 5 years 7 months .

    01 Jul 2019

  • Director Appointment

    Vajrala Bhulakshmi was appointed as a Director was appointed as a Director on 08 Jan 2019 & has been associated with this company since 6 years 1 month .

    08 Jan 2019

  • Director Appointment

    Jahnavi Puchakayala was appointed as a Director was appointed as a Director on 08 Jan 2019 & has been associated with this company since 6 years 1 month .

    08 Jan 2019

Frequently asked questions

  • Exarmed Pharma Private Limited was incorporated on 08 Jan 2019.

  • The authorized share capital of Exarmed Pharma Private Limited is ₹ 13.50 Cr and paid-up capital is ₹ 13.50 Cr.

  • Currently 4 directors are associated with Exarmed Pharma Private Limited.

    • Ganamoor Madhusudhan Reddy
    • Vajrala Bhulakshmi
    • Jahnavi Puchakayala
    • Bala Murali Krishna Thippabhotla
  • As per Ministry of Corporate Affairs (Mca), the registered address of Exarmed Pharma Private Limited is Survey 321 Plot No. 55/A Biotech Park Phase Iii Tsiic Karakapatla Village Markook Mandal Siddipet District, India, Gujvail, Telangana, 502281.

  • The corporate identification number (CIN) of Exarmed Pharma Private Limited is U24110TG2019PTC129565 and the company number is 129565 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2023, the revenue trend for Exarmed Pharma Private Limited has risen by 109.07%.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Exarmed Pharma Private Limited has experienced an upsurge of 0.27%.

  • The most recent Balance Sheet for Exarmed Pharma Private Limited was filed with the ROC on 31 Mar 2023.